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Background
Alterations in vascular relaxation have been reported in
various models of hypertension. With its tonic activity,
the NO/cGMP signalling cascade plays an important
role in the regulation of the vascular tone. In blood ves-
sels, NO is continuously being produced by the
endothelial NO synthases (eNOS) which leads to cGMP
production by stimulating the NO-sensitive guanylyl
cyclases (NO-GCs). In vascular smooth muscle cells,
two NO-GC isoforms, NO-GC1 and NO-GC2, mediate
relaxation, with NO-GC1 being responsible for approxi-
mately 90% of the NO-stimulated cGMP formation.
Deletion of eNOS or both NO-GCs abrogates endothe-
lium-dependent relaxation and causes substantial hyper-
tension. However, deletion of only NO-GC1 does not
lead to hypertension despite a 50% reduction of
endothelium-dependent relaxation.
Results
To investigate whether reduced vascular relaxation pro-
motes the development of hypertension, we induced
hypertension in NO-GC1 KO and wild-type (WT) mice
by treating the mice with angiotensin II treatment (1.44
mg / kg BW / d) for two weeks. As expected, angioten-
sin II treatment induced profound hypertension. How-
ever, blood pressure increases (~40 mmHg) and
reduction in endothelium-dependent relaxation were
similar in KO and WT mice. Also angiotensin II-
induced increases in total peripheral resistance as mea-
sured in hind-limb perfusion experiments were indistin-
guishable. Interestingly, NO-GC1 KO mice displayed
35% higher basal peripheral resistance in these
experiments.
Conclusion
Taken together, reduction of NO-stimulated cGMP pro-
duction in blood vessels by 90% does not exaggerate
angiotensin II-induced hypertension. The mechanisms
underlying this finding have to be investigated.
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